MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 5.610
- +0.610+12.20%
Close Dec 20 16:00 ET
- 5.540
- -0.070-1.25%
Post 20:01 ET
343.18MMarket Cap-1.01P/E (TTM)
5.620High4.950Low4.34MVolume5.060Open5.000Pre Close24.03MTurnover8.97%Turnover RatioLossP/E (Static)61.17MShares28.26052wk High0.62P/B271.25MFloat Cap4.62052wk Low--Dividend TTM48.35MShs Float195.970Historical High--Div YieldTTM13.40%Amplitude4.620Historical Low5.540Avg Price1Lot Size
Sage Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 22, 2024
The average Sage Therapeutics stock price target is 10.08 with a max estimate of 26.00 and a min estimate of 4.00
Review Sage Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 22, 2024
